Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLOTAVI: Short vs Long Aspirin After TAVI
NCT06518317Phase 3Recruiting
- Sponsor
- CHU Caen Normandie
- Start
- Nov 2024
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in aortic stenosis (AS), sponsored by CHU Caen Normandie. Started Nov 2024; status: recruiting.
02
Drugs
aspirin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NCT06518317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06518317.